Kepos Capital LP Edwards Lifesciences Corp Transaction History

Kepos Capital LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$52.41 - $81.0 $171,590 - $265,194	-3,274 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $234,745 - $268,762	3,274 New	3,274 $764,000
Q3 2019 Nov 13, 2019	SELL	$61.55 - $75.43 $894,629 - $1.1 Million	-14,535 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$55.74 - $64.41 $810,180 - $936,199	14,535 New	14,535 $2.69 Million
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $1.81 Million - $2.22 Million	-38,976 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$45.7 - $58.03 $12,933 - $16,422	-283 Reduced 0.72%	38,976 $6.79 Million
Q2 2018 Aug 13, 2018	BUY	$42.45 - $51.3 $1.31 Million - $1.58 Million	30,874 Added 368.21%	39,259 $5.72 Million
Q4 2017 Feb 12, 2018	BUY	$33.79 - $39.39 $283,329 - $330,285	8,385	8,385 $945,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.